hameln pharma ApS
CVR 39720213 · Private limited company (ApS) · Active · Low risk
hameln pharma ApS is a Private limited company (ApS), founded on , based in Glostrup. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 7 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 20.3m and a net result of DKK 8.1m. CEO: Stephen Allen Watkin, Frank Jahrand.
Bankruptcy risk for hameln pharma ApS
0.1 × the average (1.41%) · higher risk than 44% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39720213
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Naverland 22
2600 Glostrup - Municipality
- Albertslund
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 50k
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 83.4% |
| Current ratio | 604% |
| Moves (last 2 years) | 2 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 21 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 10.3m | DKK 6.9m | DKK 3.1m |
| Net profit | DKK 8.1m | DKK 5.3m | DKK 2.3m |
| Equity | DKK 20.3m | DKK 12.3m | DKK 7.4m |
| Total assets | DKK 24.4m | DKK 18.6m | DKK 15.5m |
| Cash | DKK 8.7m | DKK 6.9m | – |
| Short-term debt | DKK 4.0m | DKK 6.3m | – |
| Tax owed | DKK 96k | DKK 936k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 155 | ||
| 1 Jan 2024 – 31 Dec 2024 | 161 | ||
| 1 Jan 2023 – 31 Dec 2023 | 166 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 96 | ||
| 1 Jan 2020 – 31 Dec 2020 | 194 | Late | |
| 9 Jul 2018 – 31 Dec 2019 | 163 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Stephen Allen Watkin | Current | |
| CEO | Frank Jahrand | Current | |
| CEO | Dr. Christopher Klein | ||
| CEO | Marina Alexandra Stock | ||
| Owner (100%) | hameln pharma gmbh | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Founder | hameln pharma plus gmbh | Current |
Address history (3 moves)
| Naverland 22, 2600 Glostrup | |
| Strandvejen 60, 2900 Hellerup | |
| Naverland 22, 2600 Glostrup | |
| Knud Højgaards Vej 9, 2860 Søborg |
Former names
| hameln pharma ApS | – now |
| hameln nordic ApS | – |
| HPP Denmark ApS | – |
Other companies at the same address
- AHS ApS Bankrupt
- Green-TJEK ApS Bankrupt
- HOB WATCH ApS Bankrupt
- SCANKON ApS Bankrupt
- SKANDINAVISK KONVOLUT TRYK ApS Bankrupt
- AMO DENMARK ApS Active
- BIOFARMA LOGISTIK A/S Active
- Bannebjerg Holding ApS Active
- Biofarma Holding A/S Active
- EFB ELEKTRONIK NORDIC A/S Active
- EJECO A/S Fusioneret
- FRISBÆK HOLDING APS Active
- FRISBÆK ApS Active
- K. E. Hansen Holding ApS Active
- KEH Gruppen ApS Active
- NAVICO DANMARK A/S Opløst
- PHARMAVEST ApS Active
- POBRA HOLDING ApS Fusioneret
- S-COM DENMARK ApS Opløst
- Salient Pharma ApS Active
- Tinvej 13 ApS Active
Similar companies in Albertslund
- BIOFARMA LOGISTIK A/S Glostrup
- Pharma Supply ApS Albertslund
- Salient Pharma ApS Glostrup
- CONMED DENMARK ApS Glostrup
- PROTESEKOMPAGNIET A/S Albertslund
- SELMAT ApS Albertslund
- KEBOMED A/S Glostrup
- Direct Healthcare Group Danmark A/S Albertslund
- AMO DENMARK ApS Glostrup
- PHARMAVEST ApS Glostrup
- Afpro Filters ApS Albertslund
- Selskabet af 1. juli 2017 ApS Albertslund
Questions and answers about hameln pharma ApS
Has hameln pharma ApS gone bankrupt?
No, hameln pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of hameln pharma ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of hameln pharma ApS?
Stephen Allen Watkin, Frank Jahrand are the CEOs of hameln pharma ApS.
Who is the auditor of hameln pharma ApS?
hameln pharma ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was hameln pharma ApS founded?
hameln pharma ApS was founded on 9 July 2018.
What is the equity of hameln pharma ApS?
Equity was DKK 20.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.